Contrasting interspecies efficacy and toxicology of 1, 2 ‐diethy 1–3 ‐hydroxypyridin‐4‐one, CP9 4, relates to differing metabolism of the iron chelating site
The DOI matches its Crossref record.
Abstract
Summary. In order to define a predictive animal model for the effects of hydroxypyridinone (HPO) iron chelators in humans, we have compared the 28 d oral efficacy and toxicology of the HPO, 1,2‐diethyI‐3–hydroxypyridin‐4–one (CP94) in rats and guinea‐pigs and related the results to the contrasting metabolism of this compound in the two species. CP94 was highly effective at mobilizing liver iron in rats but showed toxicity at higher doses, whereas in the guinea‐pig the compound lacked toxicity but was ineffective at mobilizing liver iron. These differences can be explained by the contrasting metabolism of the drug between the two species. In rats, at the top dose of 300 mg/kg intragastrically, all animals died before the end of the study, with no deaths or weight loss at lower doses. At 100 mg/kg, rat liver non‐haem iron concentrations were reduced by 53% and 44% in females and males respectively (P<0.001). At this dose, adrenal medullary cell vacuolation, increased mammary secretory activity, vacuolation of corpora luteal cells and single cell hepatocyte necrosis were seen. There were no reductions in the white cell count. At 50 mg/kg rat liver non‐haem iron concentrations were decreased by 50% and 34% in females and males respectively (P<0.02). In female rats this was associated with increased mammary secretory activity. In iron‐overloaded rats given 100 mg/kg by gavage for 28 d, liver non‐haem iron concentration was reduced by 39% (P<0.01) and serum ferritin by 71% (P<0.001). Ovarian and mammary changes were not influenced by iron loading. In guinea‐pigs, CP94 was evaluated at 50 mg/kg, 100 mg/kg or 200 mg/kg by oral insufflation for 28 d. No reduction in liver iron was seen and no systematic dose related histological, biochemical or haematological effects were observed. Whereas in guinea‐pigs 99% of urinary recovery following an oral dose of CP94 (100 mg/kg) was as the inactive glucuronide metabolite, in the rat only 23% of the dose was excreted in the urine as the glucuronide with remainder as the free drug or an iron binding metabolite. The lack of both efficacy and toxicity in the guinea‐pig may therefore be explained by the rapid inactivation of CP94 by glucuronidation. This metabolism of CP94 in the guinea‐pig is closer to humans than the rat, suggesting that both the efficacy and toxicity of this compound in humans may also be limited by glucuronidation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Design of iron chelators with therapeutic application
Liu, Z. D., & Hider, R. C. (2002) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(02)00050-4 · Cited by 287
Self-citationDesign of clinically useful iron(III)‐selective chelators
Liu, Z. D., & Hider, R. C. (2002) · Medicinal Research Reviews · doi:10.1002/med.1027 · Cited by 266
Self-citationDesign of iron chelators with therapeutic application
Zhou, T., Ma, Y., Kong, X., & Hider, R. C. (2012) · Dalton Transactions · doi:10.1039/c2dt12159j · Cited by 136
Self-citationStabilities of 1,2-dimethyl-3-hydroxy-4-pyridinone chelates of divalent and trivalent metal ions
Clarke, E. T., & Martell, A. E. (1992) · Inorganica Chimica Acta · doi:10.1016/s0020-1693(00)80327-8 · Cited by 109
Curnow, A., Mcllroy, B., Postle-Hacon, M., Porter, J., MacRobert, A., & Bown, S. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.671 · Cited by 68
Self-citation
Metadata
- Authors
- Porter, J. B., Abeysinghe, R. D., Hoyes, K. P., Barra, C., Huehns, E. R., Brooks, P. N., Blackwell, M. P., Araneta, M., Brittenham, G., Singh, S., Dobbin, P., & Hider, R. C.
- Venue
- British Journal of Haematology
- Publisher
- Wiley
- Published
- 1993-09
- Volume
- 85
- Issue
- 1
- Pages
- 159-168
- ISSN
- 0007-1048 (ISSN-L)
- 1365-2141
- OpenAlex
- W1973263780
- Cited by
- 50
- References
- 0
- FWCI
- 0.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Contrasting interspecies efficacy and toxicology of 1, 2 ‐diethy 1–3 ‐hydroxypyridin‐4‐one, CP9 4, relates to differing metabolism of the iron chelating site. https://app.cochat.ai/papers/10.1111/j.1365-2141.1993.tb08660.x
- The paper
- Porter, J. B., Abeysinghe, R. D., Hoyes, K. P., Barra, C., Huehns, E. R., Brooks, P. N., Blackwell, M. P., Araneta, M., Brittenham, G., Singh, S., Dobbin, P., & Hider, R. C. (1993). Contrasting interspecies efficacy and toxicology of 1, 2 ‐diethy 1–3 ‐hydroxypyridin‐4‐one, CP9 4, relates to differing metabolism of the iron chelating site. British Journal of Haematology. https://doi.org/10.1111/j.1365-2141.1993.tb08660.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.